Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance. [electronic resource]
Producer: 20120914Description: 1656-63 p. digitalISSN:- 1551-4005
- Antibodies, Monoclonal -- chemistry
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- chemistry
- Apoptosis Regulatory Proteins -- antagonists & inhibitors
- Calcium-Calmodulin-Dependent Protein Kinases -- antagonists & inhibitors
- Carcinoma, Non-Small-Cell Lung -- enzymology
- Carcinoma, Squamous Cell -- enzymology
- Cell Line, Tumor
- Cetuximab
- DNA Methylation -- drug effects
- Death-Associated Protein Kinases
- Drug Resistance, Neoplasm
- Erlotinib Hydrochloride
- Head and Neck Neoplasms -- enzymology
- Humans
- Lung Neoplasms -- enzymology
- Promoter Regions, Genetic
- Quinazolines -- chemistry
- RNA Interference
- RNA, Small Interfering -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.